Linnaeus Therapeutics
Nikos is one of the directors. Nikos is a partner at the lead investor, Kairos Ventures. He went to Columbia and MIT, and he founded a few tech companies along the way. While he isn’t a scientist, he thinks what Linnaeus is doing makes a lot of sense and can help a lot of people.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Linnaeus Therapeutics
Linnaeus Therapeutics, Inc. is a privately-held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors.